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SUMMARY 
Homogeneous cGMP·dependent protein kinase catalyzes 
the rapid incorporation of phosphate, specifically into the 
inhibitory subunit of purified cardiac troponin with a max· 
imal incorporation of 1 mol of phosphate/mol of troponin. 
When troponin was incubated in the presence of both 
cGMP· and cAMP·dependent protein kinases, a maximal 
incorporation of 1 mol of phosphate/mol of troponin was 
observed which suggested phosphorylation of the same site 
by the two kinases. Both cyclic nucleotide·dependent ki· 
nases had similar Km values for troponin, but the V max value 
for the phosphorylation reaction catalyzed by cAMP·de· 
pendent protein kinase was 12·fold greater than the value 
obtained for cGMP·dependent protein kinase. 
Cyclic AMP· and cGMP.dependent protein kinases have 
recently been obtained in homogeneous form and have been 
observed to differ in cyclic nucleotide specificity and subunit 
composition (1-7). Although a number of substrates for cAMP· 
dependent protein kinase have been identified, little is known 
concerning physiologically relevant substrates for cGMP·de· 
pendent protein kinase. Because differing physiological effects 
are associated with elevated cellular concentrations of cAMP 
and cGMP, Goldberg and co·workers (B) have proposed that 
the two cyclic nucleotides mediate different and often opposing 
biochemical processes. This would imply phosphorylation of 
different substrates by the two cyclic nucleotide·dependent 
protein kinases. Although initial studies indicated that par· 
tially purified cGMP·dependent protein kinase was unable to 
activate phosphorylase kinase or inactivate glycogen synthase 
(9-11), two well documented substrates for cAMP·dependent 
protein kinase (12), recent studies have demonstrated that 
purified cGMP.dependent protein kinase catalyzed similar 
phosphorylation and/or activation of hormone· sensitive lipase, 
phosphorylase kinase, glycogen synthase, pyruvate kinase, 
fructose·1,6.diphosphatase, and histone (7, 13, 14). Troponin, 
the CaH regulatory protein of cardiac myofibrils, is another 
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well documented substrate for cAMP.dependent protein ki· 
nase. Phosphorylation of the troponin subunit which inhibits 
actomyosin ATPase activity (TN·I)' occurs in the intact rat 
heart when cAMP concentrations are elevated due to l3·adre· 
nergic stimulation (15) and in vitro when incubated in the 
presence of cAMP.dependent protein kinase (16, 17). In con· 
trast to the increases in cardiac cAMP concentrations and 
contractile force observed with l3·adrenergic agents, choliner· 
gic stimulation has been shown to cause elevations in cGMP 
content (15, 1B, 19), depression of the contractile state of the 
heart (IB), and an attenuation of the positive inotropic effects 
of isoproterenol and histamine (19). These studies indicate 
that changes in the contractile state of the heart associated 
with elevations in cAMP and cGMP content differ and may 
be related to the phosphorylation of cardiac troponin. This 
and the accompanying paper (20) report that cGMP.dependent 
protein kinase catalyzes the rapid phosphorylation of tropo· 
nino We have examined the characteristics of the phosphoryl. 
ation catalyzed by cGMP·dependent protein kinase in order 
to compare them with those obtained for cAMP.dependent 
protein kinase. 
EXPERIMENTAL PROCEDURES 
Materials - Histone H2b, buffers, and cyclic nucleotides were ob· 
tained from Sigma Chemical Co. [y.32P1ATP was prepared by the 
method of Glynn and Chappell (21). 
Preparation of Proteins - Bovine cardiac troponin· tropomyosin 
complex (TN, TM) and troponin (TN) were purified by the method 
of Stull and Buss (17). TN·TM and TN have apparent molecular 
weights of 150,000 and SO,OOO, respectively. The purified proteins 
were free of detectable kinase or phosphatase activity. 
Cyclic GMP·dependent protein kinase was purified from bovine 
lung by affinity chromatography on SNH2(CH),NH/cAMP/Sepharose (3, 5). The homogeneous enzyme had a specific activity of 1375 
units/mg. One unit of activity is that amount of enzyme which 
catalyzes the transfer of 1 nmol of"P from [y.32P1ATP into histone 
H2b per min at pH 6.S and 30°. 
Heat·stable protein inhibitor of cAMP·dependent protein kinase 
was prepared by the method of Ashby and Walsh (22). 
Enzyme Assay - Reaction mixtures containing 50 mM Tes, pH S.O, 
4 mM MgCI2, 15 mM 2·mercaptoethanol, 0.4 ILM cGMP or 10 ILM 
cAMP, 0.25 mM [y.32P1ATP (200 cpm/pmol), and TN·TM or TN 
were incubated with cGMp· or cAMP·dependent protein kinase at 
30°. Aliquots (20 ILl) were removed, spotted on Whatman No. 3MM 
filter paper squares, and processed as described (17) for measure· 
ments of protein·bound phosphate. 
RESULTS 
Phosphorylation of Troponin . Tropomyosin and Troponin 
by cGMP·dependent Protein Kinase - Incubation of bovine 
cardiac TN . TM complex with cGMP.dependent protein kinase 
resulted in the rapid incorporation of32p into protein (Fig. 1). 
No 32p incorporation was noted with TN . TM or cGMP·depend· 
ent protein kinase alone. Phosphorylation was largely com· 
plete by 40 min with a maximal incorporation of 0.B2 ± 0.06 
mol of 32p incorporated/mol of TN· TM. A similar extent of 
phosphorylation was observed with TN in the absence of TM 
(1.02 ± 0.03 mol of32P/mol of TN) . The rate of phosphorylation 
1 The abbreviations used are: TN.I, TN·C, and TN·T designate 
the inhibitory, calcium·binding, and tropomyosin·binding subunits 
of troponin, respectively; TM, tropomyosin; TN, troponin; TN ·TM, 
troponin' tropomyosin; Tes, N .tris(hydroxymethyl)methyl.2·ami. 
noethanesulfonic acid. 
334 
 at UNIV O









Phosphorylation of Cardiac Troponin 335 
oftroponin by cGMP-dependent protein kinase was stimulated 
4-fold in the presence of 0.5 iJ-M cGMP. The concentrations of 
cGMP and cAMP required for half-maximal stimulation with 
troponin as substrate were approximately 0.1 and 4 iJ-M, 
respectively. The addition of the heat-stable protein inhibitor 
of cAMP-dependent protein kinase in quantities which in-
hibited the rate of phosphorylation of TN catalyzed by cAMP-
dependent protein kinase by more than 80% had no effect on 
the rate or extent of phosphorylation of TN catalyzed by 
cGMP-dependent protein kinase. These results concerning 
the effects ofcGMP, cAMP, and the heat-stable protein kinase 
inhibitor are in agreement with previous reports which used 
histone as a substrate for the cGMP-dependent protein kinase 
(3,4,23). 
In order to determine whether the value OP2p incorporation 
into troponin after prolonged incubation reflected a saturation 
of phosphorylatable sites, additional troponin was added to 
the reaction mixture after 60 min of incubation. The rate and 
extent of phosphorylation after addition of troponin was iden-
tical with that observed during the first 60 min of incubation, 
indicating no significant loss of cGMP-dependent protein ki-
nase activity or [y_32P]ATP. 
Identification of the Phosphorylated Subunit-The stoichi-
ometry of 1 mol of 32p incorporated/mol of TN suggested 
phosphorylation of a single site by cGMP-dependent protein 
kinase, analogous to the results obtained previously with 
cAMP-dependent protein kinase (16, 17). Analysis by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis revealed 
that 88% of the radioactivity applied to the gel was associated 
with the TN-I subunit (Fig. 2). Identical results were obtained 
with bovine cardiac TN· TM. Because catalytic amounts of 
enzyme were used, autophosphorylation of cGMP-dependent 
protein kinase was not observed (24). 
Comparison of Phosphorylation of Troponin by cGMP- and 
cAMP-dependent Protein Kinases - In order to determine 
whether cGMP- and cAMP-dependent protein kinases cata-
lyzed phosphorylation of the same or different sites in TN-I, 
the effect of sequential additions of the two enzymes on the 
extent of phosphorylation was examined. As shown in Fig. 3, 
the maximal extent of phosphorylation catalyzed by each 
enzyme alone was similar (cAMP-dependent protein kinase, 
1.10 ± 0.03 (n = 3) versus cGMP-dependent protein kinase, 




FIG. 1. Phosphorylation of cardiac troponin· tropomyosin by 
cGMP-dependent protein kinase. Cardiac TN · TM (1.2 mg/ml) was 
incubated as described under "Experimental Procedures" with 
cGMP-dependent protein kinase (0.58 units/mI). 
cAMP-dependent protein kinase was added to the reaction 
mixture containing TN which had been partially phosphoryl-
ated by cGMP-dependent protein kinase (0.44 mol of 32p 
incorporated/mol of TN), the maximal extent of phosphoryla-
tion observed in the presence of both enzymes (1.01 ± 0.01 (n 
= 3) mol of 32p incorporated/mol of TN) was not significantly 
different from that catalyzed by either enzyme alone. A value 
of 2 mol of 32p incorporated/mol of TN would be expected if 
separate sites were phosphorylated by the respective kinases. 
Initial rates of TN phosphorylation were examined in order 
to compare kinetic parameters of the reactions catalyzed by 
the two kinases. As shown in Table I, the Km and V max values 
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FIG. 2. Sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis of cardiac troponin phosphorylated by cGMP-dependent protein 
kinase. Cardiac TN phosphorylated as described under "Experimen-
tal Procedures" was precipitated with 15% trichloroacetic acid and 
then dissolved in 1% sodium dodecyl sulfate. Polyacrylamide gel 
electrophoresis was performed as previously described (17). De-
stained gels were scanned for Coomassie blue absorbance at 600 nm 
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FIG. 3. Phosphorylation of cardiac troponin by cAMP- and cGMP-
dependent protein kinases. Reaction mixtures were incubated as 
described under "Experimental Procedures" with the following ad-
ditions: cAK, TN (0.39 mg/ml) and cAMP-dependent protein kinase 
(1.31 units/ml); cGK, TN (0.70 mg/ml) and cGMP-dependent protein 
kinase (13.2 units/mI). For cGK + cAK, cardiac TN (0.39 mg/ml) 
and cGMP-dependent protein kinase (0.01 units/ml) were incubated 
until 0.44 mol of 32p was incorporated/mol of TN. Cyclic AMP-
dependent protein kinase (1.08 units/m!) and cAMP (10 /kM) were 
then added to the reaction mixture and incubation continued until 
maximal phosphorylation had occurred. The maximal extent of 
phosphorylation indicated is the mean ± S.E. for at least three 
values. 
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336 Phosphorylation of Cardiac Troponin 
TABLE I 
Kinetic parameters for phosphorylation of cardiac troponin by 
cGMP-dependent and cAMP-dependent protein kinases 




16.1 ± 3.6 
20.8 ± 2.5 
p.mol 32P/min/mg kinase" 
0.93 ± 0.27 
10.9 ± 1.3 
a V max values are based upon the phosphorylation catalyzed by 
homogeneous preparations of the two kinases. One milligram of 
homogeneous cGMP-dependent protein kinase catalyzed the incor-
poration of 1375 nmol of 32P/min into histone H2b at pH 6.8 (3), 
while 1.0 mg of homogeneous cAMP-dependent protein kinase cata-
lytic subunit catalyzed the incorporation of 3300 nmol of 32P/min 
into histone type IIA at pH 6.5 (2). 
b Homogeneous catalytic subunit of cAMP-dependent protein ki-
nase was used to determine the Km and V max values presented. The 
V max value has been corrected to reflect the specific activity of 
homogeneous holoenzyme for purposes of comparison. 
for the reaction catalyzed by cGMP-dependent protein kinase 
were found to be 16.1 ± 3.6 f.LM and 0.93 ± 0.27 f.Lmol of 32p 
incorporated/min/mg of purified kinase, respectively. The K m 
and V max values obtained for cAMP-dependent protein kinase 
were 20.8 ± 2.5 f.LM and 10.9 ± 1.3 f.Lmol of 32p incorporated/ 
min/mg of purified holoenzyme, respectively. The maximal 
rate of phosphorylation of TN catalyzed by cGMP-dependent 
protein kinase occurred between pH 8.0 and 9.0, similar to 
that previously reported for the cAMP-dependent protein 
kinase-catalyzed reaction (17). 
DISCUSSION 
The present studies indicate that cGMP-dependent protein 
kinase catalyzes the maximal incorporation of 1 mol of 32P/ 
mol of TN-I, identical with that previously reported for cAMP-
dependent protein kinase (17). Incubation of TN in the pres-
ence of both kinases also results in a maximal extent of phos-
phorylation of 1 mol of 32P/mol of TN, suggesting that both 
kinases catalyze phosphorylation of the same site in TN-I. 
Because studies in the intact heart indicate that phosphoryla-
tion of TN-I occurs in response to elevated concentrations of 
cAMP, but not to elevated concentrations of cGMP (15), the 
kinetics of the two in vitro reactions were compared. Although 
the Km values for troponin phosphorylation by cAMP- and 
cGMP-dependent protein kinase were similar, the V max values 
for the cAMP-dependent protein kinase-catalyzed reaction 
exceeded that for the cGMP-dependent protein kinase-cata-
lyzed reaction by 12-fold. Taken in conjunction with the 
apparent ll-fold greater amounts of cAMP-dependent protein 
kinase present in the heart (25), phosphorylation of TN-I by 
cAMP-dependent protein kinase in the intact heart would 
occur at a rate 130-fold greater than the cGMP-dependent 
reaction, if both kinases were fully activated. The kinetic 
studies presented here are the first which can satisfactorily 
explain why elevations in cGMP content in the intact heart 
are not associated with TN-I phosphorylation (15). Increases 
in cGMP concentration in the intact heart are instead associ-
ated with the dephosphorylation of TN-I (15), suggesting a 
complex role for cGMP in regulating the phosphorylation and 
dephosphorylation of TN-I. 
Recently a comparison of cGMP-dependent protein kinase 
with cAMP-dependent protein kinase suggested structural 
and evolutionary parallelisms in the two enzymes (5-7). It is, 
therefore, not surprising to find that the two enzymes are 
capable of phosphorylating some of the same substrates in 
vitro, albeit at different rates. However, cAMP and cGMP 
often appear to mediate differing and opposing physiological 
effects, presumably by stimulating phosphorylation of differ-
ent substrates by the respective kinases. Thus, many sub-
strates which may be phosphorylated in vitro by both kinases 
are apparently only phosphorylated in vivo by one of the 
kinases at a rate sufficient to result in a biochemical effect. 
The results presented here emphasize the importance of ob-
taining kinetic parameters for the phosphorylation of proteins 
in vitro in order to evaluate the potential significance of such 
reactions in vivo. 
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